Re:Age

https://longevity.technology/news/lilly-races-to-become-first-longevity-big-pharma/

https://www.technologyreview.com/2026/10/06/1145836/weight-loss-drugs-glp1-lilly-novo-aging-clocks

I was recently interviewed for a Marie Claire piece on the blue zones, article found here, and it made me question something I hadn’t really thought about – something slightly uncomfortable. I often talk about the Blue Zones, with my patients in a consult or on a panel discussion and even often on my Instagram or other public facing commentary, yet the data behind some of these populations is a bit shaky. Knowing this, and being a scientist…why do I keep recommending the habits anyway?

Ready? Let’s dive in…

Thyroid disease: symptoms, suffering in silence and wht the evidence really says about autoimmunity

There is a phrase people use at funerals, “she died of a broken heart.” We say it the way we say the sun rises, knowing perfectly well that it does not, using the sentence for what it carries rather than for what it claims.

I used to file it under sentiment: heart attacks were plumbing, something narrows, something ruptures, a clot forms, muscle downstream starts to die and grief was in the mind, and the mind, I assumed, stayed in its lane, until i learnt about what happened in Niigata

Bryan Johnson built his life around the belief that biological decline could be negotiated with. Measured, tracked, interrogated and adjusted, every part of the body became something to watch more closely.

He did not merely become interested in health. He turned his body into a living experiment in control.

And then came the sentence that made the whole project feel suddenly more human.

“My stomach is eating itself.”

A healthy 37-year-old man almost skipped his appointment. What we found changed everything.

This episode explores the shift from a world of sudden death to one of slow disease, and why the future of medicine lies not in treating illness after it appears, but in recognising biological change while there is still time to alter the trajectory.

This episode explores one of the biggest conversations emerging in health right now: microplastics, endocrine disruption and the quiet erosion of fertility.

From PCOS (recently renamed PMOS) and hormonal signalling to inflammation, oxidative stress and IVF outcomes, we examine how modern environmental exposures may be influencing reproductive health in ways medicine is only beginning to understand.

It’s a conversation about fertility, modern life and the invisible exposures the body is now adapting to every single day.

In this episode, I explore what wearables are actually showing us, not just data, but the loss of our ability to feel ourselves clearly. From heart rate variability to sleep and glucose, these devices are not creating new information. They are restoring access to signals we’ve become disconnected from.

I walk through the physiology behind what your wearable is measuring, why behaviour changes when biology becomes visible, and where these tools can both help and harm. This is not about optimisation. It is about awareness, pattern recognition, and intervening earlier, while the body is still adaptable.

The question is not which wearable to buy.It is what has changed in your life that you need one to see what your body is already trying to tell you.

In this episode, we examine loneliness as a chronic biological stressor. Associated with a mortality risk similar to smoking 15 cigarettes a day, it can accelerate biological ageing by around four years. We unpack how this shapes the nervous system, immunity, and aging itself.

Peptides are everywhere right now. Promising faster recovery, better sleep, and improved muscle repair. But what do they actually do and why do so many people feel like they need them? This episode breaks down the science, the hype, and what the peptide trend reveals about modern biology.